AWG
ABUS icon

Alpha Wave Global’s Arbutus Biopharma ABUS Stock Holding History

Alpha Wave Global’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,115,263
Closed -$3.63M – 22
2017
Q1 		$3.63M Sell
1,115,263
-539,899
-33% -$1.5M 0.36% 25
2016
Q4 		$4.05M Sell
1,655,162
-962,838
-37% -$2.8M 0.43% 24
2016
Q3 		$9.01M Hold
2,618,000
– – 0.71% 24
2016
Q2 		$9.11M Hold
2,618,000
– – 0.67% 21
2016
Q1 		$10.8M Hold
2,618,000
– – 0.71% 25
2015
Q4 		$11.7M Hold
2,618,000
– – 0.75% 21
2015
Q3 		$15.9M Hold
2,618,000
– – 1.1% 16
2015
Q2 		$31M Buy
2,618,000
+397,000
+18% +$6.04M 2.36% 15
2015
Q1 		$38.8M Buy
+2,221,000
New +$45.5M 1.9% 17

Other funds holding ABUS

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Alpha Wave Global's ABUS Position: Q2 2017 in Review

Alpha Wave Global sold out of Arbutus Biopharma (ABUS) in Q2 2017, closing a stake of 1,115,263 shares — an estimated $3.63M sold.

Alpha Wave Global first reported a position in ABUS in Q1 2015 and held it in 9 quarters. The position peaked at $38.8M in Q1 2015. 50 funds tracked by Wall St. Rank hold ABUS as of Q2 2017.

  • Alpha Wave Global reported no remaining Arbutus Biopharma position as of Q2 2017 after selling out during the quarter.
  • Alpha Wave Global sold 1,115,263 Arbutus Biopharma shares in Q2 2017, an estimated $3.63M.
  • Alpha Wave Global first reported a position in Arbutus Biopharma in Q1 2015 and held it in 9 quarters.
  • Alpha Wave Global's Arbutus Biopharma position peaked at $38.8M in Q1 2015.
  • 50 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2017.

Based on Alpha Wave Global's 13F filing for Q2 2017, filed 14 Aug 2017.